Anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: Long-term outcome

Although basiliximab and rabbit anti-thymocyte globulin (ATG) are effective in delaying and reducing the incidence of acute rejection (AR) thus improving short-term graft survival, their impact on long-term graft survival has not been well established in renal transplant recipients. To evaluate the...

Full description

Bibliographic Details
Main Authors: Sailaja Kesiraju, Purna Paritala, Uma Maheswara Rao Ch, Srinivasa Murthy Athmakuri, V S Reddy, S Sahariah
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2014;volume=25;issue=1;spage=9;epage=15;aulast=Kesiraju